Eledon Pharmaceuticals, Inc. Interest and Other Income
Eledon Pharmaceuticals, Inc. (ELDN) reported Interest and Other Income of $26.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-03.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2017-05-03
- Eledon Pharmaceuticals, Inc. interest and other income for the quarter ending 2017-03-31 was $26.00K, a 51.85% decline year-over-year.
- Eledon Pharmaceuticals, Inc. interest and other income for the quarter ending 2016-12-31 was $23.00K, a 58.18% decline year-over-year.
- Eledon Pharmaceuticals, Inc. interest and other income for the quarter ending 2016-09-30 was $38.00K, a 29.63% decline year-over-year.
- Eledon Pharmaceuticals, Inc. interest and other income for the quarter ending 2016-06-30 was $49.00K, a 96.00% increase year-over-year.
- Eledon Pharmaceuticals, Inc. interest and other income for fiscal 2016 was $164.00K, a 5.75% decline from fiscal 2015.
- Eledon Pharmaceuticals, Inc. interest and other income for fiscal 2015 was $174.00K, a 4.82% increase from fiscal 2014.
- Eledon Pharmaceuticals, Inc. interest and other income for fiscal 2014 was $166.00K.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2017-03-31 | $26.00K 10-Q · filed 2017-05-03 | $49.00K derived: sum of 2 quarters · filed 2017-05-03 | $87.00K derived: sum of 3 quarters · filed 2017-05-03 | $136.00K derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $61.00K derived: sum of 2 quarters · filed 2017-03-03 | $110.00K derived: sum of 3 quarters · filed 2017-03-03 | $164.00K 10-K · filed 2017-03-03 |
| 2016-09-30 | $38.00K 10-Q · filed 2016-11-03 | $87.00K derived: sum of 2 quarters · filed 2016-11-03 | $141.00K 10-Q · filed 2016-11-03 | $196.00K derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-06-30 | $49.00K 10-Q · filed 2016-08-04 | $103.00K 10-Q · filed 2016-08-04 | $158.00K derived: sum of 3 quarters · filed 2017-05-03 | $212.00K derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-03-31 | $54.00K 10-Q · filed 2017-05-03 | $109.00K derived: sum of 2 quarters · filed 2017-05-03 | $163.00K derived: sum of 3 quarters · filed 2017-05-03 | $188.00K derived: sum of 4 quarters · filed 2017-05-03 |
| 2015-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $109.00K derived: sum of 2 quarters · filed 2017-03-03 | $134.00K derived: sum of 3 quarters · filed 2017-03-03 | $174.00K 10-K · filed 2017-03-03 |
| 2015-09-30 | $54.00K 10-Q · filed 2016-11-03 | $79.00K derived: sum of 2 quarters · filed 2016-11-03 | $119.00K 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $25.00K 10-Q · filed 2016-08-04 | $65.00K 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $40.00K 10-Q · filed 2015-05-12 | |||
| 2014-12-31 | $166.00K 10-K · filed 2017-03-03 | |||
| 2014-06-30 | $34.00K 10-Q · filed 2015-08-12 | $79.00K 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | $45.00K 10-Q · filed 2015-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |